VERA · Company research
Vera Therapeutics, Inc. Class A Common Stock (VERA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Small Cap Consumer Research raises target for Vera Bradley stock to USD 7.00 - ad-hoc-news.de | Small Cap Consumer Research raises target for Vera Bradley stock to USD 7.00 ad-hoc-news.de | View source ↗ | ad-hoc-news.de | Oct 20, 2026 | neutral | 0 | 0.6 |
| Ennis CFO Vera Burnett Exercises 2,000 ISOs at $17.27, Updates Stock Holdings - Kalkine Media | Ennis CFO Vera Burnett Exercises 2,000 ISOs at $17.27, Updates Stock Holdings Kalkine Media | View source ↗ | Kalkine Media | Oct 20, 2026 | neutral | 0 | 0.6 |
| Vera Therapeutics (VERA) Stock Dropped, So What Is Behind The Move? - Simply Wall Street | Vera Therapeutics (VERA) Stock Dropped, So What Is Behind The Move? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 17, 2026 | neutral | 0 | 0.6 |
| Vera Bradley: Strong Cash, No External Debt, But Profits Still Need Proof (NASDAQ:VRA) - Seeking Alpha | Vera Bradley: Strong Cash, No External Debt, But Profits Still Need Proof (NASDAQ:VRA) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 16, 2026 | neutral | 0 | 0.6 |
| Vera Bradley (NASDAQ:VRA) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell? - MarketBeat | Vera Bradley (NASDAQ:VRA) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell? MarketBeat | View source ↗ | MarketBeat | Oct 15, 2026 | neutral | 0 | 0.6 |
| Vera Bradley: Despite 140% Rally, The Stock Is Still Undervalued - Seeking Alpha | Vera Bradley: Despite 140% Rally, The Stock Is Still Undervalued Seeking Alpha | View source ↗ | Seeking Alpha | Oct 15, 2026 | neutral | 0 | 0.6 |
| Avoiding Lag: Real-Time Signals in (VERA) Movement - Stock Traders Daily | Avoiding Lag: Real-Time Signals in (VERA) Movement Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 14, 2026 | neutral | 0 | 0.6 |
| Fast-paced Momentum Stock Vera Bradley (VRA) Is Still Trading at a Bargain - Yahoo Finance | Fast-paced Momentum Stock Vera Bradley (VRA) Is Still Trading at a Bargain Yahoo Finance | View source ↗ | Yahoo Finance | Oct 12, 2026 | neutral | 0 | 0.6 |
| VERA Jan 2028 12.500 call (VERA280121C00012500) Interactive Stock Chart - Yahoo! Finance Canada | VERA Jan 2028 12.500 call (VERA280121C00012500) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 10, 2026 | neutral | 0 | 0.6 |
| Vera Therapeutics, Inc. Stock 12‑Month Price Target Cut to $77.07, Implies 159% Upside - TradingView | Vera Therapeutics, Inc. Stock 12‑Month Price Target Cut to $77.07, Implies 159% Upside TradingView | View source ↗ | TradingView | Oct 9, 2026 | neutral | 0 | 0.6 |
| Nvidia Has Already Made Investors Rich. Here’s Where the Stock Could Be Headed Next - 24/7 Wall St. | Nvidia Has Already Made Investors Rich. Here’s Where the Stock Could Be Headed Next 24/7 Wall St. | View source ↗ | 24/7 Wall St. | Oct 9, 2026 | neutral | 0 | 0.6 |
| VERA Stock Surges After Drug To Treat Rare Kidney Disease Gets FDA Approval – Retail Sees The Move As Catalyst For Vera Therapeutics - Stocktwits | VERA Stock Surges After Drug To Treat Rare Kidney Disease Gets FDA Approval – Retail Sees The Move As Catalyst For Vera Therapeutics Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| Ivan Brockman Bought 36% More Shares In Vera Bradley - Simply Wall Street | Ivan Brockman Bought 36% More Shares In Vera Bradley Simply Wall Street | View source ↗ | Simply Wall Street | Oct 9, 2026 | neutral | 0 | 0.6 |
| NVDA Stock Rises Premarket: Vera Rubin AI Accelerator Delivers 2X Profit Per GW Than Blackwell, Semianalysis Says - Stocktwits | NVDA Stock Rises Premarket: Vera Rubin AI Accelerator Delivers 2X Profit Per GW Than Blackwell, Semianalysis Says Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| Vera Bradley (NASDAQ:VRA) Stock: Insider Ivan Brockman Buys 10,000 Shares - MarketBeat | Vera Bradley (NASDAQ:VRA) Stock: Insider Ivan Brockman Buys 10,000 Shares MarketBeat | View source ↗ | MarketBeat | Oct 7, 2026 | neutral | 0 | 0.6 |
| Meta-Analysis Shows Ropeginterferon Alfa-2b Benefit Over Phlebotomy, but Not Hydroxyurea, in Polycythemia Vera - OncLive | Meta-Analysis Shows Ropeginterferon Alfa-2b Benefit Over Phlebotomy, but Not Hydroxyurea, in Polycythemia Vera OncLive | View source ↗ | OncLive | Oct 7, 2026 | neutral | 0 | 0.6 |
| Most shorted stocks on Wall Street - Seeking Alpha | Most shorted stocks on Wall Street Seeking Alpha | View source ↗ | Seeking Alpha | Oct 5, 2026 | neutral | 0 | 0.6 |
| HPE Stock Jumps 7% on Nvidia Vera CPU Server Bet [2026] - shattered.io | HPE Stock Jumps 7% on Nvidia Vera CPU Server Bet [2026] shattered.io | View source ↗ | shattered.io | Oct 4, 2026 | neutral | 0 | 0.6 |
| Five new hires at Vera Therapeutics received share options and awards that vest over four years. - Stock Titan | Five new hires at Vera Therapeutics received share options and awards that vest over four years. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| $VERA stock is up 7% today. Here's what we see in our data. - Quiver Quantitative | $VERA stock is up 7% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 24, 2026 | neutral | 0 | 0.6 |
| Vera Therapeutics (VERA) Stock Looks Fully Valued After Its 185% Run - Yahoo Finance | Vera Therapeutics (VERA) Stock Looks Fully Valued After Its 185% Run Yahoo Finance | View source ↗ | Yahoo Finance | Jul 10, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.